How should hyperphosphatemia be managed in dialysis patients?
D017610:Calcium Compounds / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D010710:Phosphates / Q000097:blood* / Q000378:metabolism; D010760:Phosphorus Metabolism Disorders / Q000188:drug therapy* / Q000209:etiology*; D011322:Primary Prevention / Q000379:methods*; D011379:Prognosis; D006435:Renal Dialysis / Q000009:adverse effects* / Q000379:methods; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D014807:Vitamin D / Q000008:administration & dosage*
D017610:Calcium Compounds; D010710:Phosphates; D014807:Vitamin D